Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Dive

Showing results (61-70 of 214) with videos related to

Pageof 22
Sort By:
Nature Communications|April 4, 2025
A human model to deconvolve genotype-phenotype causations in lung squamous cell carcinomaJulia Ogden, Robert Sellers, Sudhakar Sahoo, et al.
The Journal of Biological Chemistry|February 25, 2003
Post-translational modification of Bid has differential effects on its susceptibility to cleavage by caspase 8 or caspase 3Mauro Degli Esposti, Gilles Ferry, Peggy Masdehors, et al.
Clinical Drug Investigation|January 6, 2012
A pilot study assessing the prognostic value of CK18 and nDNA biomarkers in severe sepsis patientsDavid J Moore, Alastair Greystoke, Fouziah Butt, et al.
Open Biology|January 13, 2021
Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectoriesRobert E Hynds, Kristopher K Frese, David R Pearce, et al.
Biomarker Insights|August 8, 2009
DNA methylation in circulating tumour DNA as a biomarker for cancerRuth E Board, Lucy Knight, Alastair Greystoke, et al.
Bioinformatics (Oxford, England)|December 7, 2018
In silico error correction improves cfDNA mutation callingChang Sik Kim, Sumitra Mohan, Mahmood Ayub, et al.
Melanoma Research|November 9, 2013
Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanomaLeila Khoja, Patrick Shenjere, Clare Hodgson, et al.
Trends in Molecular Medicine|September 5, 2024
Cell-free and extrachromosomal DNA profiling of small cell lung cancerRoya Behrouzi, Alexandra Clipson, Kathryn L Simpson, et al.
Neoplasia (New York, N.Y.)|April 9, 2014
BMX acts downstream of PI3K to promote colorectal cancer cell survival and pathway inhibition sensitizes to the BH3 mimetic ABT-737Danielle S Potter, Paul Kelly, Olive Denneny, et al.
Molecular Cancer Research : MCR|June 11, 2009
Blocking phosphoinositide 3-kinase activity in colorectal cancer cells reduces proliferation but does not increase apoptosis alone or in combination with cytotoxic drugsCristina Martin-Fernandez, Juliana Bales, Cassandra Hodgkinson, et al.
Pageof 22

Showing results (61-70 of 214) with videos related to

Sort By:
Pageof 22
Nature Communications|April 4, 2025
A human model to deconvolve genotype-phenotype causations in lung squamous cell carcinomaJulia Ogden, Robert Sellers, Sudhakar Sahoo, et al.
The Journal of Biological Chemistry|February 25, 2003
Post-translational modification of Bid has differential effects on its susceptibility to cleavage by caspase 8 or caspase 3Mauro Degli Esposti, Gilles Ferry, Peggy Masdehors, et al.
Clinical Drug Investigation|January 6, 2012
A pilot study assessing the prognostic value of CK18 and nDNA biomarkers in severe sepsis patientsDavid J Moore, Alastair Greystoke, Fouziah Butt, et al.
Open Biology|January 13, 2021
Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectoriesRobert E Hynds, Kristopher K Frese, David R Pearce, et al.
Biomarker Insights|August 8, 2009
DNA methylation in circulating tumour DNA as a biomarker for cancerRuth E Board, Lucy Knight, Alastair Greystoke, et al.
Bioinformatics (Oxford, England)|December 7, 2018
In silico error correction improves cfDNA mutation callingChang Sik Kim, Sumitra Mohan, Mahmood Ayub, et al.
Melanoma Research|November 9, 2013
Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanomaLeila Khoja, Patrick Shenjere, Clare Hodgson, et al.
Trends in Molecular Medicine|September 5, 2024
Cell-free and extrachromosomal DNA profiling of small cell lung cancerRoya Behrouzi, Alexandra Clipson, Kathryn L Simpson, et al.
Neoplasia (New York, N.Y.)|April 9, 2014
BMX acts downstream of PI3K to promote colorectal cancer cell survival and pathway inhibition sensitizes to the BH3 mimetic ABT-737Danielle S Potter, Paul Kelly, Olive Denneny, et al.
Molecular Cancer Research : MCR|June 11, 2009
Blocking phosphoinositide 3-kinase activity in colorectal cancer cells reduces proliferation but does not increase apoptosis alone or in combination with cytotoxic drugsCristina Martin-Fernandez, Juliana Bales, Cassandra Hodgkinson, et al.
Pageof 22